Crossref


1. Advancements in Antiviral Therapy: Favipiravir Sodium in Nasal Formulation

- Priti Darne

- Shankar Vidhate

- Somesh Shintre

- Somnath Wagdare

- Dhiraj Bhamare

- Nisha Mehta

- Vishal Rajagopalan

- Sriram Padmanabhan

2. Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management

- Xichuan Li

- Wanting Wang

- Suying Yan

- Weipeng Zhao

- Hui Xiong

- Cuiping Bao

- Jinqian Chen

- Yuan Yue

- Yanjun Su

- Chunze Zhang

3. The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies

- Dang The Hung

- Suhaib Ghula

- Jeza Muhamad Abdul Aziz

- Abdelrahman M. Makram

- Gehad Mohamed Tawfik

- Ali Ahmed-Fouad Abozaid

- Rohan Andrew Pancharatnam

- Amr Mohamed Ibrahim

- Muhammad Besher Shabouk

- Morgan Turnage

- Saloni Nakhare

- Zahra Karmally

- Basel Kouz

- Tran Nhat Le

- Suleiman Alhijazeen

- Nguyen Quoc Phuong

- Alaa Mohamed Ads

- Ali Hussein Abdelaal

- Nguyen Hai Nam

- Tatsuo Iiyama

- Kyoshi Kita

- Kenji Hirayama

- Nguyen Tien Huy